Eli Lilly & Co.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $4.20B | $17.63B | $3.83B |
| FY2014 | $5.33B | $15.37B | $3.87B |
| FY2015 | $7.97B | $14.57B | $3.67B |
| FY2016 | $8.37B | $14.01B | $4.58B |
| FY2017 | $9.94B | $11.59B | $6.54B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $4.20B | $17.63B | $3.83B |
| FY2014 | $5.33B | $15.37B | $3.87B |
| FY2015 | $7.97B | $14.57B | $3.67B |
| FY2016 | $8.37B | $14.01B | $4.58B |
| FY2017 | $9.94B | $11.59B | $6.54B |